Clinical Study of Acupoint Application of Tingli Shengmai Wuling Powder Combined with Routine Western Medicine in the Treatment of Chronic Heart Failure
返回论文页
|更新时间:2022-10-08
|
Clinical Study of Acupoint Application of Tingli Shengmai Wuling Powder Combined with Routine Western Medicine in the Treatment of Chronic Heart Failure
Fu Yuna, MA Xiujuan, TANG Jing, et al. Clinical Study of Acupoint Application of Tingli Shengmai Wuling Powder Combined with Routine Western Medicine in the Treatment of Chronic Heart Failure. [J]. 21(1):27-29(2021)
Fu Yuna, MA Xiujuan, TANG Jing, et al. Clinical Study of Acupoint Application of Tingli Shengmai Wuling Powder Combined with Routine Western Medicine in the Treatment of Chronic Heart Failure. [J]. 21(1):27-29(2021) DOI: 10.14009/j.issn.1672-2124.2021.01.007.
Clinical Study of Acupoint Application of Tingli Shengmai Wuling Powder Combined with Routine Western Medicine in the Treatment of Chronic Heart Failure
OBJECTIVE: To investigate the clinical efficacy of acupoint application of Tingli Shengmai Wuling powder combined with routine western medicine in the treatment of chronic heart failure. METHODS: Totally 120 patients with chronic heart failure admitted into Shijiazhuang Traditional Chinese Medicine Hospital from Jan. 2016 to Feb. 2019 were extracted to be divided into the control group( routine western medicine) and the research group( acupoint application of Tingli Shengmai Wuling powder on the basis of the control group) via the random number table
with 60 cases in each group. Differences of clinical efficacy
cardiac function
serum high sensitivity C-reactive protein( hs-CRP)
serum brain natriuretic peptide( BNP)
serum interleukin 6( IL-6)
serum tumor necrosis factor α( TNF-α) and adverse drug reactions of two groups were compared. RESULTS: After treatment of 2 weeks
the total effective rate of the study group was 88. 33%( 53/60)
significantly higher than 70. 00%( 42/60) of the control group
the difference was statistically significant( P < 0. 05). Compared with before treatment
after treatment of 2 weeks
the left ventricular end-systolic diameter( LVESD)
the left ventricular ejection fraction( LVEF) and 6 min walking distance increased significantly
differences were statistically significant( P < 0. 05). After treatment of 2 weeks
the levels of LVESD
LVEDD
hs-CRP
BNP
IL-6 and TNF-α in the study group were significantly lower than those in the control group at the same period
while the levels of LVEF were significantly higher than those in the control group at the same period
and the 6 min walking distance was significantly longer than that in the control group at the same period
with statistically significant differences( P < 0. 05). The incidence of adverse drug reactions in the control group and the study group were respectively 13. 33%( 8/60) and 15. 00%( 9/60)
the difference was not statistically significant( P > 0. 05). CONCLUSIONS: The efficacy of acupoint application of Tingli Shengmai Wuling powder combined with routine western medicine in the treatment of chronic heart failure is significant
which can effectively improve the cardiac function of patients and serum hs-CRP
BNP
IL-6 and TNF-α levels without increasing the incidence of adverse drug reactions.
关键词
葶苈生脉五苓散穴位敷贴慢性心力衰竭临床研究
Keywords
Tingli Shengmai Wuling powderAcupoint applicationChronic heart failureClinical research
Effect of Modified Chaihu Shugan Powder Combined with Acupoint Application on Sleep Process and Sleep Structure in Patients with Sleep Disorder of Liver-Depression and Qi-Stagnation
Clinical Observation of Shexiang Baoxin Pills Combined with Ivabradine in the Treatment of Patients with Chronic Heart Failure and Chronic Obstructive Pulmonary Disease
Three-Drug Combination Regimen Containing Low-Dose Bortezomib in the Treatment of Elderly Multiple Myeloma
Clinical Research on Comprehensive Management Mode of Adverse Drug Reactions of Highly Emetogenic Chemotherapy Drugs in the Treatment of Lung Cancer
Efficacy and Mechanism of Danhong Injection Combined with Conventional Therapy in Patients with Chronic Heart Failure
Related Author
DOU Ronghua
ZHAO Na
MA Yanli
YUAN Pingping
ZHANG Wanhui
LIU Xianxia
ZHANG Yuansheng
CHEN Lei
Related Institution
Dept.of Neurology, Canzhou Central Hospital
Dept.of Encephalopathy, Hebei Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine
Dept.of Cardiology, the Second Affiliated Hospital of Hainan Medical College
Dept. of Hematology, Harrison International Peace Hospital
Cancer Center, Beijing Friendship Hospital, Capital Medical University